Newsfeeds - Spark Newswire

1 minute read

Why Nurix Therapeutics Shares Are Rising Today

Today, 11:29 PM

Nurix Therapeutics Inc (NASDAQ: NRIX) shares are trading higher by 13.25% to $17.52 Friday afternoon after the company announced a registered direct offering for total gross proceeds of approximately $40 million.

NRIX

2 minute read

Earnings

Nurix Therapeutics’s Return On Capital Employed Insights

By Benzinga Insights

Today, 11:29 PM

Benzinga Pro data, Nurix Therapeutics (NASDAQ:NRIX) reported Q2 sales of $11.43 million. Earnings fell to a loss of $45.40 million, resulting in a 6.74% decrease from last quarter.

NRIX

3 minute read

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

By Vandana Singh

Today, 11:29 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADCT

2 minute read

News

Nurix Therapeutics Announces $40M Registered Direct Offering

By Bill Haddad

Today, 11:29 PM

Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs, today announced that it has entered into a securities purchase agreement with two

NRIX

1 minute read

Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY

By Bill Haddad

Today, 11:29 PM

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.

NRIX

4 minute read

69 Biggest Movers From Friday

By Lisa Levin

Today, 11:29 PM

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

ACOR

3 minute read

40 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 11:29 PM

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

ACOR

2 minute read

Analyst Ratings

Analyst Ratings for Nurix Therapeutics

By Benzinga Insights

Today, 11:29 PM

Within the last quarter, Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings:

NRIX

6 minute read

88 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:29 PM

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

AFRM

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 11:29 PM

APYX